ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma

The combination of ARID1A loss plus CD8+ T-cell infiltration indicated a favorable prognosis and responsiveness to both chemotherapy and immunotherapy. These findings provide valuable insights for developing novel therapeutic strategies and improving treatment stratification for urothelial carcinoma.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-08-11
DOI
https://doi.org/10.1158/1078-0432.ccr-25-0816
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma

Kaifeng Jin, Weijuan Zhang, Zewei Wang, Yuan Chang et al.
1 citations
Clinical Cancer Research
Cancer Immunotherapy and Biomarkers
1.05
article

ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma

Kaifeng Jin, Weijuan Zhang, Zewei Wang, Yuan Chang, Zhaopei Liu, Yawei Ding, Yuzhen Wu, Jiejie Xu, Lingkai Zhang, Xiaohe Su, Han Zeng, Yu Zhu, Le Xu, Hailong Liu, Jiaxing Sun
article en
1 citations

Abstract

The combination of ARID1A loss plus CD8+ T-cell infiltration indicated a favorable prognosis and responsiveness to both chemotherapy and immunotherapy. These findings provide valuable insights for developing novel therapeutic strategies and improving treatment stratification for urothelial carcinoma.

Clinical Cancer ResearchVol. 31(20)
Shanghai Medical College of Fudan University (CN), Army Medical University (CN), Sun Yat-sen University (CN), Fudan University (CN), XinHua Hospital (CN), Ruijin Hospital (CN), Fudan University Shanghai Cancer Center (CN), Xinqiao Hospital (CN), Zhongshan Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN)
Gilead Sciences, Natural Science Foundation of Shanghai, Shanghai Anti-Cancer Association, Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shanghai Education Development Foundation, Fudan University, Shanghai Municipal Education Commission, Shanghai Municipal Health Bureau, Army Medical University
Good health and well-being
Openalex Percentile: Top 19%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.